Randomised Control Trial of A Proactive Intervention Supporting Recovery in Relation To Stress and Irregular Work Hours - Effects On Sleep, Burn-Out, Fatigue and Somatic Symptoms
Randomised Control Trial of A Proactive Intervention Supporting Recovery in Relation To Stress and Irregular Work Hours - Effects On Sleep, Burn-Out, Fatigue and Somatic Symptoms
Randomised Control Trial of A Proactive Intervention Supporting Recovery in Relation To Stress and Irregular Work Hours - Effects On Sleep, Burn-Out, Fatigue and Somatic Symptoms
Original research
influence of stress, homoeostatic and circadian factors on sleep— 15 or higher indicates clinical insomnia. A sleep quality index
was used as a pedagogical approach to summarise research-based was calculated based on the mean of four items from the Karo-
knowledge about what regulates sleep. The sessions had three linska Sleep Questionnaire (KSQ)27 (Cronbach’s alpha=0.77)
main focuses: (1) unwinding from stress, including detach- rating the frequency of sleep problems (1 always—6 never).
ment from thoughts of work during free time; (2) supporting
sleep in relation to homoeostatic and circadian processes; and
(3) handling fatigue and increasing recovery behaviours (see
Burn-out, fatigue and cognitive weariness
Burn-out symptoms during the last month were measured
table 1). Psychoeducative elements were interspersed with
with the Shirom- Melamed Burn- out Questionnaire (SMBQ)
group discussions and exercises. Participants were encouraged
consisting of 22 items (1 almost never—7 almost always).28 29 A
to reflect on their habitual behaviours connected to sleep and
global mean score was calculated (Cronbach’s a=0.95), and the
recovery and possible alternatives. Between sessions, the partic-
two indices: ‘fatigue’ (Cronbach’s a=0.89) and ‘cognitive weari-
ipants were encouraged to try strategies or behaviour changes
ness’ (Cronbach’s a=0.94).
of their choice, with the aim of enhancing sleep and recovery.
During the second and third sessions, participants reflected on
the experience of trying new strategies. All participants received Work-Induced fatigue
written material covering the content of each session, as well as Work-induced fatigue during free time was measured with the
online access to an adapted version of a biomathematical model Work Interference with Personal Life index (WIPL) from the
(ArturNurse). ArturNurse evaluated fatigue risk levels based on Work Home Interference scale30 based on the mean of four items
their work schedules25 and provided suggestions of strategies (Cronbach’s alpha=0.90) measuring the extent to which work
from the programme on how to optimise sleep in relation to related fatigue affects free-time (1 not at all—5 almost all the
different shifts. See online supplemental file 1 for more detail time). Scores of ≥3.5 indicates work-home interference.31
about the intervention.
Somatic symptoms
Background measures
Somatic symptoms were measured with the Somatic Symptom
In the baseline questionnaire, participants reported gender
Scale-8 (SSS8), which assesses the experience of eight somatic
(male, female, other), age (years), duration of working as a nurse
symptoms (eg, headache, stomach problems, back pain) during
(months), type of shift schedules, if they took any medication
the last 7 days (0 not at all—4 much). A sum score was calcu-
(yes/no), and frequency of the use of sleep medication, central
lated (Cronbach’s alpha=0.75). Scores 8–11 indicate a medium
stimulants, sedatives, opioid analgesics or other pain killers (1
somatic symptom burden, 12–15 indicate high and 16–32 indi-
never, 5 every day).
cate very high.32
PRIMARY OUTCOMES
Sleep SECONDARY OUTCOMES
Insomnia symptoms during the last month were measured with Perceived stress
the Insomnia Severity Index (ISI; 0 no problems—4 severe prob- Perceived stress during the last month was measured with the
lems).26 A sum score was calculated (Cronbach’s alpha=0.84), Perceived Stress Scale (PSS) consisting of 10 items (0 never—4
Table 2 Estimated group means and tests of effects, taken from a multilevel analysis of the primary outcome measures using an intention to treat approach
Cohen’s d between
Estimated group means Tests of effects groups
Intervention Control Group Time Group * Time
Follow-
Mean SE 95% CI Mean SE 95% CI F P value df F P value df F P value Post up
ISI 2.88 0.09 185.39 6.73 0.00 148.41 2.57 0.08 0.30 0.39
Baseline 10.65 0.51 9.64 to 11.66 10.74 0.49 9.78 to 11.71
Post 8.83 0.54 7.76 to 9.90 10.15 0.52 9.12 to 11.19
Follow-up 8.83 0.59 7.66 to 10.00 10.58 0.54 9.51 to 11.65
KSQ 1.02 0.31 196.14 11.25 0.00 153.04 0.75 0.47 −0.22 −0.17
Baseline 4.07 0.10 3.87 to 4.27 4.03 0.10 3.84 to 4.22
Post 4.42 0.10 4.22 to 4.62 4.23 0.10 4.04 to 4.43
Follow-up 4.34 0.11 4.11 to 4.56 4.20 0.10 4.00 to 4.40
SMBQ Global 1.45 0.23 190.01 0.17 0.84 149.74 4.03 0.02 0.36 0.19
Baseline 3.74 0.12 3.51 to 3.97 3.71 0.11 3.49 to 3.93
Post 3.54 0.12 3.30 to 3.77 3.89 0.11 3.67 to 4.12
Follow-up 3.66 0.12 3.43 to 3.90 3.84 0.11 3.63 to 4.06
SMBQ Fatigue 3.90 0.05 187.18 1.05 0.35 147.17 3.87 0.02 0.45 0.30
Baseline 3.73 0.13 3.48 to 3.98 3.79 0.12 3.55 to 4.02
Post 3.62 0.14 3.35 to 3.88 4.14 0.13 3.89 to 4.40
Follow-up 3.64 0.14 3.37 to 3.91 3.96 0.13 3.71 to 4.21
SMBQ Cognitive 0.10 0.76 189.40 0.43 0.65 147.13 3.53 0.03 0.24 0.03
Baseline 3.47 0.15 3.17 to 3.77 3.33 0.14 3.04 to 3.61
Post 3.16 0.16 2.85 to 3.47 3.47 0.15 3.18 to 3.77
Follow-up 3.37 0.16 3.06 to 3.69 3.37 0.15 3.08 to 3.66
WIPL Fatigue 0.31 0.58 184.30 0.44 0.65 149.17 5.37 0.01 0.33 0.02
Baseline 3.43 0.09 3.25 to 3.62 3.32 0.09 3.14 to 3.49
Post 3.20 0.10 2.99 to 3.40 3.48 0.10 3.29 to 3.68
Follow-up 3.30 0.11 3.08 to 3.51 3.32 0.10 3.13 to 3.52
SSS8 4.48 0.04 176.33 16.30 0.00 132.72 3.81 0.03 0.37 0.49
Baseline 10.82 0.61 9.61 to 12.03 11.25 0.58 10.11 to 12.39
Post 11.73 0.69 10.36 to 13.09 13.67 0.65 12.38 to 14.95
Follow-up 11.96 0.73 10.51 to 13.41 14.69 0.68 13.36 to 16.02
Factor labels in tests of effects: Group=Intervention vs Control, Time=Baseline vs Post vs Follow-up, Group*time=interaction term. Df (df) for Time and Group*time are identical.
ISI, Insomnia Severity Index, 0–28 severe problems; KSQ, Karolinska Sleep Questionnaire, 1 always— 6 never; Mean, modelled mean values; SMBQ, Shirom-Melamed Burn-out Questionnaire, 1 almost never—7 almost always; SSS8, Somatic Symptom Scale-8, 0–32 very high somatic symptom burden;
WIPL, Work Interference with Personal Life, 1 not at all—5 almost all the time.
Figure 2 Mean values and SEs in intervention and control group at baseline, post and follow-up measures. DBAS, Dysfunctional Beliefs and Attitudes
about Sleep, 0 do not agree–10 do fully agree; ISI, Insomnia Severity Index, 0–28 severe problems; KSQ, Karolinska Sleep Questionnaire, 1 always–6 never;
PSS, Perceived Stress Scale, 0 never–40 very often; SSS8, Somatic Symptom Scale-8, 0–32 very high somatic symptom burden; SMBQ, Shirom-Melamed
Burn-out Questionnaire, 1 almost never–7 almost always; WIPL, Work Interference with Personal Life, 1 not at all–5 almost all the time.
DISCUSSION showed stable ratings for these symptoms, while the control
This study examined whether a proactive intervention for group showed increased somatic symptoms over time. Further,
newly graduated RNs, supporting strategies for the enhance- promising effects were seen on burn-out measures and on work-
ment of sleep and recovery in relation to work stress and shift induced fatigue during free time at postintervention. However,
work, could prevent negative development of sleep problems, these latter effects did not persist at follow-up 6 months later.
burn-out, fatigue and somatic symptoms. The results indicated a The intervention group showed lower global burn-out scores
preventive effect on somatic symptoms, as the intervention group compared with the control group, as well as lower scores on
Dahlgren A, et al. Occup Environ Med 2022;79:460–468. doi:10.1136/oemed-2021-107789 465
466
Workplace
Table 3 Estimated group means and tests of effects, taken from a multilevel analysis of the secondary outcome measures using an intention to treat approach
Estimated group means Tests of effects Cohen’s d between groups
Intervention Control Group Time Group * Time
Mean SE 95% CI Mean SE 95% CI F P value df F P value df F P value Post Follow-up
PSS 0.08 0.78 175.63 0.52 0.60 144.83 2.24 0.11 0.22 0.01
Baseline 18.34 0.75 16.87 to 19.81 17.77 0.66 16.48 to 19.07
Post 16.95 0.70 15.56 to 18.34 18.23 0.66 16.93 to 19.53
Follow-up 17.64 0.78 16.10 to 19.18 17.63 0.70 16.25 to 19.01
SMBQ Tense 0.05 0.82 191.85 2.78 0.07 148.94 0.89 0.41 0.03 0.14
Baseline 3.83 0.13 3.58 to 4.08 3.75 0.12 3.51 to 3.99
Post 3.66 0.14 3.38 to 3.94 3.69 0.14 3.42 to 3.96
Follow-up 3.82 0.15 3.54 to 4.11 3.98 0.13 3.72 to 4.24
SMBQ Listlessness 1.99 0.16 190.88 0.59 0.56 150.50 2.89 0.06 0.39 0.15
Baseline 4.06 0.13 3.81 to 4.31 4.11 0.12 3.88 to 4.35
Post 3.81 0.12 3.57 to 4.05 4.21 0.12 3.98 to 4.45
Follow-up 3.99 0.14 3.72 to 4.27 4.16 0.13 3.91 to 4.41
DBAS 1.32 0.25 153.20 1.15 0.32 129.95 2.94 0.06 0.26 0.32
Baseline 5.34 0.20 4.94 to 5.74 5.27 0.19 4.89 to 5.65
Post 4.91 0.23 4.46 to 5.36 5.36 0.21 4.94 to 5.79
Follow-up 5.00 0.23 4.54 to 5.45 5.51 0.21 5.10 to 5.93
Factor labels in tests of effects: Group=Intervention vs Control, Time=Baseline vs Post vs Follow-up. Df (df) for Time and Group*time are identical.
DBAS, Dysfunctional Beliefs and Attitudes about Sleep, 0 do not agree—10 do fully agree; Mean, modelled mean values; PSS, Perceived Stress Scale, 0 never—40 very often; SMBQ, Shirom-Melamed Burn-out Questionnaire.